AVXL granted patent protection until 2036, plus po
Post# of 1460
(Total Views: 301)
Posted On: 06/01/2023 10:22:52 AM
AVXL granted patent protection until 2036, plus possible extensions, for the crystal form of blarcamesine (what we know as 2-73). This "is exceptionally important.... because all clinical trials with Anavex 2-73.... are using the patent protected crystal forms as the active pharmaceutical ingredient."
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼